Cholera Vaccine: Recommendations of the Advisory Committee on Immunization Practices, 2022

This report describes previously published ACIP recommendations about use of CVD 103-HgR for adults aged 18-64 years and introduces a new recommendation for use in children and adolescents aged 2-17 years. ACIP recommends CVD 103-HgR, the only cholera vaccine licensed for use in the United States, for prevention of cholera among travelers aged 2-64 years to an area with active cholera transmission. Health care providers can use these guidelines to develop the pretravel consultation for persons traveling to areas with active cholera transmission.PMID:36173766 | DOI:10.15585/mmwr.rr7102a1

Source: MMWR Recomm Rep - September 29, 2022 Category: Epidemiology Authors: Jennifer P Collins Edward T Ryan Karen K Wong Matthew F Daley Adam J Ratner Grace D Appiah Pablo J Sanchez Bruce J Gutelius Source Type: research